SKLB 610

• Description:

  SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  415.37

• Molecular Formula:

  C21H16F3N3O3

• Notes:

  Research use only, not for human use.

• Receptor:

  FGFR| PDGFR| VEGFR

• CAS Number:

  1125780-41-7